Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Sales (ltm)

Akebia Therapeutics Price / Sales (ltm) Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Sales (ltm) from 2017 to 2020.
  • Akebia Therapeutics Price / Sales (ltm) for the quarter ending September 09, 2020 was 1.24 a 8.47% increase of 0.11 year over year
  • Akebia Therapeutics Price / Sales (ltm) for the last 12 months ending September 09, 2020 was 1.24 a 8.47% increase of 0.11 year over year
  • Akebia Therapeutics Annual Price / Sales (ltm) for 2020 was 1.24 a 9.49% increase of 0.12 from 2019
  • Akebia Therapeutics Annual Price / Sales (ltm) for 2020 was 1.12 a 1.12% increase of 0.01 from 2019
  • Akebia Therapeutics Annual Price / Sales (ltm) for 2020 was 1.11 a -2.27% decrease of -0.03 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA Price / Sales (ltm) Data

09/20201.24
09/20201.12
09/20201.11
09/20201.14
09/20201.07
09/20201.10
09/20201.12
09/20201.10
09/20201.15
09/20201.12

Annual AKBA Price / Sales (ltm) Data

20201.24
20201.12
20201.11
20201.14
20201.07
20201.10
20201.12
20201.10
20201.15
20201.12